Clinical trial
Dexamethasone for Palliation - Brain Metastases
NCT00188864 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188864 |
|---|---|
| Title | Dexamethasone for Palliation - Brain Metastases |
| Official title | Dexamethasone as Palliative Treatment in Addition to Radiation Therapy for Patients With Brain Metastases: A Prospective Study |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | dexamethasone |
| Enrollment | 50 |
| Start date | Nov 1, 2003 |
| Primary completion | Nov 1, 2006 |
| Completion | Jan 28, 2019 |
| First posted | Sep 16, 2005 |
| Last update posted | Nov 27, 2019 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: